CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma

Author：              

Publisher： Spandidos Publications

E-ISSN： 1791-2423|47|6|2100-2106

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.47, Iss.6, 2015-01, pp. : 2100-2106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma

By                  

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1157-1164

Spandidos Publications

Access to resources Recommend Favorite

Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma

By                      

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 50-58

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma

By            

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 595-602

Spandidos Publications

Access to resources Recommend Favorite

Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma

By Shrikhande Shailesh   Kleeff Jörg  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 118-127

Springer Publishing Company

Access to resources Recommend Favorite

Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma

By                

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 931-936

Spandidos Publications

Access to resources Recommend Favorite